Nasdaq

Interesting ACAD Put And Call Options For January 2022

Investors in Acadia Pharmaceuticals Inc (Symbol: ACAD) saw new options become available today, for the January 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Seeking Alpha

ACADIA Pharmaceuticals Inc. (ACAD) Q4 2022 Earnings Call Transcript

Good day, ladies and gentlemen. And welcome to ACADIA Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Gigi, and I will be your coordinator for today. At ...
The Globe and Mail

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operating Overview

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the fourth quarter and full year ended December 31, 2022. NUPLAZID ® delivered net sales of $136.5 million in the ...
The Globe and Mail

Acadia Pharmaceuticals Reports Third Quarter 2022 Financial Results

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the third quarter ended September 30, 2022. NUPLAZID delivered net sales of $130.7 million in the third quarter of ...
Nasdaq

Interesting ACAD Put And Call Options For February 2022

Investors in Acadia Pharmaceuticals Inc (Symbol: ACAD) saw new options become available today, for the February 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Stockhouse

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced financial results for the fourth quarter and full year ended December 31, 2021. “Acadia delivered strong fourth quarter and full year results ...